UBS Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $237M | Buy |
2,758,615
+1,385,250
| +101% | +$121M | 0.03% | 570 |
|
|
2026
Q1 | $124M | Buy |
1,373,365
+556,119
| +68% | +$51M | 0.02% | 891 |
|
|
2025
Q4 | $73.5M | Sell |
817,246
-124,244
| -13% | -$11.8M | 0.01% | 1261 |
|
|
2025
Q3 | $92.7M | Sell |
941,490
-168,475
| -15% | -$16.7M | 0.01% | 1080 |
|
|
2025
Q2 | $101M | Buy |
1,109,965
+292,413
| +36% | +$28.3M | 0.02% | 948 |
|
|
2025
Q1 | $92.5M | Buy |
817,552
+209,942
| +35% | +$22.5M | 0.02% | 987 |
|
|
2024
Q4 | $64.2M | Buy |
607,610
+70,445
| +13% | +$7.56M | 0.01% | 1242 |
|
|
2024
Q3 | $58M | Buy |
537,165
+81,795
| +18% | +$8.93M | 0.01% | 1055 |
|
|
2024
Q2 | $49.4M | Sell |
455,370
-92,053
| -17% | -$10.9M | 0.01% | 1045 |
|
|
2024
Q1 | $72.2M | Buy |
547,423
+284,444
| +108% | +$35.5M | 0.02% | 821 |
|
|
2023
Q4 | $32M | Sell |
262,979
-160,681
| -38% | -$17.9M | 0.01% | 1262 |
|
|
2023
Q3 | $47.5M | Sell |
423,660
-150,804
| -26% | -$19.2M | 0.02% | 887 |
|
|
2023
Q2 | $83.6M | Buy |
574,464
+226,176
| +65% | +$30.7M | 0.03% | 567 |
|
|
2023
Q1 | $45M | Buy |
348,288
+19,634
| +6% | +$2.47M | 0.02% | 837 |
|
|
2022
Q4 | $41.9M | Buy |
328,654
+135,462
| +70% | +$15.7M | 0.02% | 913 |
|
|
2022
Q3 | $20.2M | Sell |
193,192
-229,228
| -54% | -$25.2M | 0.01% | 1268 |
|
|
2022
Q2 | $44.4M | Buy |
422,420
+90,609
| +27% | +$10.7M | 0.02% | 792 |
|
|
2022
Q1 | $42.4M | Sell |
331,811
-119,631
| -26% | -$14.4M | 0.01% | 944 |
|
|
2021
Q4 | $55.7M | Sell |
451,442
-790
| -0.2% | -$103K | 0.02% | 894 |
|
|
2021
Q3 | $64.3M | Sell |
452,232
-103,987
| -19% | -$15.3M | 0.02% | 732 |
|
|
2021
Q2 | $86.8M | Buy |
556,219
+87,664
| +19% | +$14.2M | 0.03% | 570 |
|
|
2021
Q1 | $72.8M | Sell |
468,555
-31,947
| -6% | -$4.95M | 0.02% | 644 |
|
|
2020
Q4 | $74.9M | Buy |
500,502
+76,350
| +18% | +$10.8M | 0.03% | 588 |
|
|
2020
Q3 | $56.1M | Buy |
424,152
+13,032
| +3% | +$1.7M | 0.02% | 610 |
|
|
2020
Q2 | $47.6M | Sell |
411,120
-22,096
| -5% | -$2.55M | 0.02% | 635 |
|
|
2020
Q1 | $42.5M | Buy |
433,216
+81,702
| +23% | +$10.7M | 0.02% | 612 |
|
|
2019
Q4 | $51.1M | Buy |
351,514
+41,260
| +13% | +$5.7M | 0.02% | 767 |
|
|
2019
Q3 | $41.3M | Buy |
310,254
+127,608
| +70% | +$16.5M | 0.02% | 791 |
|
|
2019
Q2 | $20.9M | Sell |
182,646
-174,254
| -49% | -$20.4M | 0.01% | 1189 |
|
|
2019
Q1 | $44.2M | Buy |
356,900
+108,936
| +44% | +$12.4M | 0.02% | 705 |
|
|
2018
Q4 | $25M | Sell |
247,964
-11,990
| -5% | -$1.35M | 0.01% | 942 |
|
|
2018
Q3 | $33.2M | Buy |
259,954
+17,582
| +7% | +$2.09M | 0.01% | 886 |
|
|
2018
Q2 | $26.2M | Sell |
242,372
-148,179
| -38% | -$16.1M | 0.01% | 1000 |
|
|
2018
Q1 | $41.3M | Sell |
390,551
-91,928
| -19% | -$10.7M | 0.02% | 729 |
|
|
2017
Q4 | $56.5M | Buy |
482,479
+250,627
| +108% | +$28.3M | 0.02% | 619 |
|
|
2017
Q3 | $26.4M | Sell |
231,852
-841,066
| -78% | -$97.1M | 0.01% | 941 |
|
|
2017
Q2 | $134M | Buy |
1,072,918
+887,517
| +479% | +$105M | 0.07% | 296 |
|
|
2017
Q1 | $22M | Sell |
185,401
-81,379
| -31% | -$9.22M | 0.01% | 975 |
|
|
2016
Q4 | $26.7M | Buy |
266,780
+72,277
| +37% | +$7.75M | 0.01% | 852 |
|
|
2016
Q3 | $24.6M | Sell |
194,503
-1,331
| -0.7% | -$164K | 0.01% | 853 |
|
|
2016
Q2 | $22.9M | Buy |
195,834
+29,329
| +18% | +$3.32M | 0.01% | 856 |
|
|
2016
Q1 | $17.2M | Sell |
166,505
-11,516
| -6% | -$1.11M | 0.01% | 984 |
|
|
2015
Q4 | $17.7M | Buy |
178,021
+16,933
| +11% | +$1.66M | 0.01% | 1027 |
|
|
2015
Q3 | $14.7M | Buy |
161,088
+6,937
| +5% | +$695K | 0.01% | 1097 |
|
|
2015
Q2 | $16.3M | Sell |
154,151
-30,756
| -17% | -$3.4M | 0.01% | 1118 |
|
|
2015
Q1 | $21.1M | Buy |
184,907
+81,392
| +79% | +$9.29M | 0.01% | 923 |
|
|
2014
Q4 | $11.4M | Buy |
+103,515
| New | +$10.9M | 0.01% | 1404 |
|
Other funds holding ZBH
UBS Group's ZBH Position: Q2 2026 in Review
UBS Group increased its Zimmer Biomet (ZBH) stake by 101% in Q2 2026, buying an estimated $121M and bringing the position to 2,758,615 shares worth $237M. The position accounts for 0.03% of the portfolio, ranked #570.
UBS Group first reported a position in ZBH in Q4 2014 and has held it in 47 quarters since. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- UBS Group held 2,758,615 shares of Zimmer Biomet worth $237M as of Q2 2026.
- UBS Group bought 1,385,250 Zimmer Biomet shares in Q2 2026, an estimated $121M.
- Zimmer Biomet made up 0.03% of UBS Group's portfolio in Q2 2026, its #570 holding.
- UBS Group first reported a position in Zimmer Biomet in Q4 2014 and has held it in 47 quarters since.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.